Topical corticosteroid use for atopic dermatitis in the pediatric emergency department.

Abstract

To investigate the evaluation and management of atopic dermatitis (AD) in the pediatric emergency department (PED). This retrospective chart review was performed at the PED of a single institution and examined data from 2012 to 2017. Of 335 visits from patients 18years and younger coded for AD, 167 visits with documented findings that supported a diagnosis of AD according to guidelines from the American Academy of Dermatology were included. The mean age of presentation was 6.3years (standard deviation [SD]: 5.9). Of 11 patients with multiple visits, the mean between-visit interval was 31days (SD: 41). Topical corticosteroids (TCSs) were not prescribed or recommended in 63/167 visits. In an additional 46/167 visits, over-the-counter topical hydrocortisone was recommended. Of prescribed TCS, the mean TCS class was 5.5 (SD: 1.9). 61/104 recommended or prescribed TCSs were weak (Class 7), the most likely used class (P<.001). Dermatology consultation was requested in 14/167 visits and was associated with higher rates of TCS prescriptions (13/14 vs 91/153, P=.018), a higher mean class of TCS prescribed (3.1 vs 5.9, P<.001), higher prescription rates of systemic antibiotics (8/14 vs 10/153, P<.001), and higher recommendation rates for emollient usage (10/14 vs 46/153, P=.005). Most patients presenting to the PED for AD were either not prescribed a TCS or were prescribed a weak TCS, often one that is over-the-counter. While there may be a variety of explanations for these findings, it is possible they reveal a practice gap regarding AD management in the PED.